sábado, 19 de enero de 2013

Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study

Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study

Predicting the cost and pace of pharmacogenomic advances: An evidence-based studyExternal Web Site Icon
Ramy Arnaout, Thomas P. Buck, Paulvalery Roulette,and Vikas P. Sukhatme 2013 Clinical Chemistry 59:4

No hay comentarios: